Transcriptional Regulation of Oct4 in Human Bone Marrow Mesenchymal Stem Cells
Authors:
- 1 March 2011
- journal article
- research article
- Published by SAGE Publications in Stem Cells and Development
- Vol. 20 (3) , 441-449
Abstract
Oct4 is a key transcription factor to maintain self-renewal and undifferentiated state of embryonic stem cells. Site 2A located between −2,546 and −2,530 bp and site 2B between −2,500 and −2,486 bp of human Oct4 gene were shown to be sufficient for inducing Oct4 gene expression in embryonic stem cells. Site 2B contains octamer element capable of binding to factor Oct4 and sox element capable of binding to factor Sox2. So far, little is known about the molecular mechanisms for the control of growth and differentiation of adult stem cells including bone marrow–derived mesenchymal stem cells (BM-MSCs), and it is important to understand how Oct4 expression is regulated in BM-MSCs. This study showed that Oct4 and Sox2 genes were expressed in undifferentiated BM-MSCs and BM-MSCs on day 7 but not on days 14 and 21 following osteogenic induction. Site 2A of Oct4 gene, not site 2B, activated the expression of reporter genes luciferase and enhanced green fluorescent protein in undifferentiated BM-MSCs but not in BM-MSCs following osteogenic differentiation. These data demonstrate that site 2A is sufficient for inducing the expression of Oct4 gene in BM-MSCs, and site 2B is not required. Electrophoretic mobility shift assay showed the 2 shifted bands with site 2B probe and the addition of Oct4 and Sox2 antibodies did not supershift these 2 bands. As probes containing mutated octamer and sox elements of site 2B still gave the same 2 shifted bands, it was concluded that they did not result from the binding to site 2B probe by factors Oct4 and Sox2. These bands may be due to the binding of 2 unknown transcription factors.Keywords
This publication has 33 references indexed in Scilit:
- Differentiation of Wharton's Jelly Primitive Stromal Cells into Insulin-Producing Cells in Comparison with Bone Marrow Mesenchymal Stem CellsTissue Engineering Part A, 2009
- Endothelial differentiation of Wharton's jelly–derived mesenchymal stem cells in comparison with bone marrow–derived mesenchymal stem cellsExperimental Hematology, 2009
- Growth of Human Umbilical Cord Wharton's Jelly-Derived Mesenchymal Stem Cells on the Terpolyester Poly(3-hydroxybutyrate-co-3-hydroxyvalerate-co-3-hydroxyhexanoate)Journal of Biomaterials Science, Polymer Edition, 2009
- Differentiation of mesenchymal stromal cells derived from umbilical cord Wharton's jelly into hepatocyte-like cellsCytotherapy, 2009
- Mesenchymal Stem Cells Derived from CD133‐Positive Cells in Mobilized Peripheral Blood and Cord Blood: Proliferation, Oct4 Expression, and PlasticityStem Cells, 2005
- Core Transcriptional Regulatory Circuitry in Human Embryonic Stem CellsCell, 2005
- Comparison of Gene Expression of Umbilical Cord Vein and Bone Marrow–Derived Mesenchymal Stem CellsStem Cells, 2004
- Transdifferentiation potential of human mesenchymal stem cells derived from bone marrowThe FASEB Journal, 2004
- Linker length and composition influence the flexibility of Oct‐1 DNA bindingThe EMBO Journal, 1997
- The POU domain: versatility in transcriptional regulation by a flexible two-in-one DNA-binding domain.Genes & Development, 1995